Join us on September 21st for an ActiGraph webinar.
Operationalizing Digital Health Technologies: Successes and Failures in Clinical Research
Register Now

ActiGraph Announces Official Partnership with Chinese Reseller, B&E Teksystems

Pensacola, FL – May 24, 2021–ActiGraph, a leading global provider of medical-grade wearable...
1 Minute Read
Read More

VeraSci Partners with ActiGraph to Expand the Use of Wearables in Clinical Trials

Durham, NC – January 19, 2021–VeraSci, a global clinical research company offering eClinical...
1 Minute Read
Read More

ActiGraph Promotes Jeremy Wyatt to Chief Executive Officer

Pensacola, FL – June 8, 2020– ActiGraph, a leading provider of medical-grade wearable physical...
1 Minute Read
Read More

ActiGraph Announces Acquisition by ArchiMed

Pensacola, FL – May 18, 2020– ActiGraph, a leading provider of medical-grade wearable physical...
2 Minute Read
Read More

snapIoT Announces Another Successful mHealth Integration in One WeekActiGraph/snapClinical Integration Advances Data Collection for Decentralized Clinical Trials

San Diego (PRWEB) MAY 18, 2020:snapIoT announces a successful integration of its mClinical...
2 Minute Read
Read More

Signant Health and ActiGraph simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with integration

Philadelphia, PA – November 14, 2019:Signant Health, formerly CRF Health and Bracket, is proud to...
2 Minute Read
Read More

ActiGraph Partners with VivoSense to Enhance Secure Access to Regulated Sensor Data from Patients in Pharmaceutical Clinical Trials

May 22, 2019, Pensacola, FL – Pensacola, FL–ActiGraph, the leading provider of medical-grade...
2 Minute Read
Read More

ActiGraph Earns ISO-13485:2016/MDSAP Certification

Feb 06, 2019 – Pensacola, FL– ActiGraph announced today that it has earned International...
1 Minute Read
Read More

Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint to Detect Improvements in Pulmonary Fibrosis Patients

WARREN, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH)...
Read More
1 2 3